Rob Chess

Entrepreneur

Rob Chess is a serial entrepreneur in the life sciences field and is the former CEO and current Chairman of Nektar Therapeutics, (NASDAQ:NKTR), as well as the Lead Director of Twist Biosciences (NASDAQ:TWST) and a lecturer at the Stanford Graduate School of Business. His previous experiences includes Cofounder and President of Penederm (Acq. by Mylan Laboratories), start-up CEO and Chairman of OPX Biotechnologies (Acq. by Cargill), Co-founder and Chairman of Biota Technologies. Rob also served as a White House Fellow and Associate Director of the White House Office of Economic and Domestic Policy. In addition to his entrepreneurial endeavors and activities at the Stanford GSB, Rob is a trustee of Caltech and Chairman of the Caltech Board Technology Transfer Committee, and on the boards of Bio Ventures for Global Health. Rob received a BS in engineering from Caltech and an MBA from Harvard Business School.

About Us

Who we are

We are an interdisciplinary, STEM-focused team supported by experienced leaders, world-class advisors, and top-notch investors.